Insight Molecular Diagnostics (IMDX) Income from Continuing Operations (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Income from Continuing Operations of 4413000.0 for Q1 2026, down 125.74% sequentially from 17142000.0 in Q4 2025, and up 35.09% YoY from 3266628.96 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Income from Continuing Operations data on file, last reported at 4413000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 35.09% year-over-year to 4413000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8161000.0 (up 20.54% YoY) and the FY2025 annual result came in at 10547000.0, up 17.21% from the prior year.
- Income from Continuing Operations retreated to 4413000.0 in Q1 2026 per IMDX's latest filing, from 17142000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 17142000.0 in Q4 2025, with the low at 15992000.0 in Q4 2023.
- Average Income from Continuing Operations over 5 years is 4178117.65, with a median of 6489000.0 recorded in 2023.
- The widest YoY moves for Income from Continuing Operations: up 274.6% in 2023, down 510.92% in 2023.
- Insight Molecular Diagnostics' Income from Continuing Operations stood at 12017000.0 in 2022, then tumbled by 33.08% to 15992000.0 in 2023, then soared by 191.76% to 14675000.0 in 2024, then increased by 16.81% to 17142000.0 in 2025, then plunged by 125.74% to 4413000.0 in 2026.
- Business Quant data shows IMDX's Income from Continuing Operations at 4413000.0 in Q1 2026, 17142000.0 in Q4 2025, and 11048000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.41 Mn |
| Dec 31, 2025 | 17.14 Mn |
| Sep 30, 2025 | -11.05 Mn |
| Jun 30, 2025 | -9.84 Mn |
| Mar 31, 2025 | -6.80 Mn |
| Dec 31, 2024 | 14.68 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -4.63 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -15.99 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | 5.96 Mn |
| Dec 31, 2022 | -12.02 Mn |
| Sep 30, 2022 | -1.82 Mn |
| Jun 30, 2022 | -1.36 Mn |
| Mar 31, 2022 | -3.41 Mn |
| Dec 31, 2021 | -35.69 Mn |
| Sep 30, 2021 | -13.80 Mn |
| Jun 30, 2021 | -10.49 Mn |